The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Covexin 8 Suspension for injection for sheep and cattle

Zoetis Belgium S.A.VPA10387/009/001

Main Information

Trade NameCovexin 8 Suspension for injection for sheep and cattle
Active SubstancesC. novyi type B anaculture
C. septicum toxoid
C. tetani toxoid
C. haemolyticum anaculture
C. perfringens type b & c ß toxoid
C. perfringens type d (e) toxoid
C. chauvoei whole culture
Dosage FormSuspension for injection
Licence HolderZoetis Belgium S.A.
Licence NumberVPA10387/009/001

Group Information

ATC CodeQI02AB01 clostridium
QI04AB01 clostridium
Therapeutic ClassImmunological - Inactivated Vaccine


License statusAuthorised
Licence Issued11/07/2014
Legal StatusLR: Licensed Retailer as defined in national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back